Background: Nebulised therapy is commonly used in the management of patients with asthma and chronic obstructive pulmonary disease (COPD). There are guidelines setting out standards for maintenance of the compressor and replacement and care of consumables. This study surveys patients using nebulisers to ascertain the reported use and maintenance of the nebulisers and any side effects related to therapy. Methods: An anonymous postal questionnaire, requesting information on nebuliser use and maintenance, and side effects was sent to 200 patients who had been maintained on nebuliser therapy and had been in contact with the nebuliser service at Glasgow Royal Infirmary within the last year. Results: One hundred and seventeen (58.5%) questionnaires were returned completed or partially completed for analysis. The majority of patients who replied were female (median age of 69 years). The most commonly reported diagnosis was COPD (87/117); 92/117 (79%) were smokers or ex-smokers. The most commonly reported side effects associated with treatment are dry mouth, tremor and chest tightness. The responses to questions on servicing, maintenance and replacement of consumables indicate that patients comply poorly with these activities. Additionally compliance with the prescribed drug regimen occurs in less than 50% of the patient cohort. Conclusions: The results of this study indicate that compliance with instructions given on the care and maintenance of home nebulisers may be suboptimal. Additionally patients reported poorer compliance than was predicted. These areas may be improved with the introduction of a new patient information leaflet.
Introduction
Nebulisers are commonly used in the management of airways disease and are the subject of a British Thoracic Society (BTS) Guideline. 1 The majority of nebulisers are used for the delivery of beta agonists and anticholinergic agents and less commonly for steroids and antiinfective agents. They are used both in acute situations and in maintenance regimens. Patients with chronic obstructive pulmonary disease (COPD) are often prescribed both a bronchodilator and an anticholinergic agent on a regular basis while asthmatic patients, using a nebuliser, may either take their medication as required or on a regular basis. 2, 3 For the majority of patients maintained on nebulised agents at home, a jet nebuliser, which comprises a nebulising chamber and an electrical compressor, is used for the delivery of the drugs. Within the BTS guideline 1 for the use of nebulisers there are some suggestions 4 for the maintenance of the compressor and the replacement of the consumables required for efficient operation of the nebulisers. These suggest that the compressor should be serviced annually; at this time the filter is normally replaced on the compressor. Consumables, mouthpiece, mask and tubing should be replaced regularly at 3-6 monthly intervals and the nebuliser chamber should be washed in hot soapy water, rinsed and left to dry naturally once daily. It is also suggested that patients should receive an information leaflet and instruction on how to use the equipment.
Previous studies on the compliance with therapy have either optimised the patient's technique, with repeated instruction 5 or have used electronic devices to log the use of the nebuliser. 6 To our knowledge this is the first study that relies on patient reported data and also investigates the patients cleaning and maintenance of their nebulisers.
The aim of this study was to survey patients who had received a nebuliser from the respiratory unit at Glasgow Royal Infirmary to ascertain how they use and maintain their nebuliser at home and what if any, side effects relating to their treatment.
Methods
Nebulisers are issued to patients from the Department of Respiratory Medicine following a review by a Respiratory Consultant and a 2-week trial of medication using an appropriate nebuliser device and compressor system. The correct use of the nebuliser is demonstrated and a medication prescription and written instructions for the routine care and cleaning of the nebuliser chamber and compressor system are issued. Before the trial of treatment, spirometry and a symptom and activity questionnaire are completed. These are repeated following the 2-week trial to assess symptomatic benefit. If there is symptomatic improvement on the validated questionnaires and the patient has expressed willingness to continue nebuliser treatment, then a permanent nebuliser is issued. The patient is given consumables to last a year and is informed that an appointment for routine maintenance and electrical safety check of the equipment will be sent at an appropriate time.
The study was carried out using an anonymous postal questionnaire. The questionnaire was designed to collect data on a variety of areas of interest relating to the use of nebulisers by patients in their homes. The questionnaire was split into sections on demographics, information about the nebuliser and its use, side effects related to the treatments, and the servicing and maintenance of the nebuliser unit. The questions were all closed questions and an explanatory letter was included.
The questionnaire was posted to 200 randomly selected patients who were identified from the database of patients who had had a nebuliser issued from the respiratory unit at Glasgow Royal Infirmary and who had been in contact with the service within the last year. Patients were excluded if their nebuliser had not been serviced within the last year. A reply paid envelope was issued but followup of the non-responding patients was not possible due the anonymity requested by the ethics committees.
Data from the returned questionnaires were entered into a secure database. Ten percent of the data entries were validated for accuracy. Descriptive statistics were used in the analysis of data.
The study had ethical approval from the North Glasgow University NHS Trust Research ethics committee and the University of Strathclyde ethics committee. The ethics committee also reviewed the questionnaire before use.
Results
There are currently 682 nebuliser systems on loan from the Department of Respiratory Medicine to 418 women and 264 men. Of the 200 questionnaires posted to 130 women and 70 men, 117 (58.5%) were returned completed or partially completed. There
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was no statistically significant difference (w 2 ¼ 0:05; P40:5; DF ¼ 1) between the population who have nebulisers supplied by the hospital and those who responded to the questionnaire. The demographics of the study population are shown in Table 1 .
Patients with self-reported diagnosis of asthma had been diagnosed a median (IQR) of 17. 5 (11-30) years ago while the patients with a self-reported diagnosis of COPD had been diagnosed 10 (5-10) years ago. The source and length of time the patients had used their nebuliser indicate that the majority were hospital initiated and the patients with asthma had been using their nebulisers for a longer period of time. Patients appeared to consult their GP more often than they were seen by the secondary care services. When asked if they followed the advice given 77/114 (67.5%) indicated that they always did. This, however, was not confirmed by later questions on the cleaning and replacement of disposables (Tables 2-4) , which indicate poor compliance with the recommended servicing, cleaning and replacement regimens.
It was also recorded in the respiratory database that the majority of patients were prescribed their nebulised solutions four times a day and it was expected that this would be confirmed in answer to the question ' ' How often do you use your nebuliser?'' The results in Table 5 suggest that less than half the patients use their nebuliser in this way, with the asthmatic patients showing poorer compliance than the patients with COPD. Table 6 indicates the side effects of treatment identified by the patients.
Discussion
The population of patients included in this study was chosen to reflect the patients who have recently had their nebuliser serviced and are in contact with the nebuliser service at Glasgow Royal Infirmary. These patients reflect the population of patients who have a home nebuliser supplied by the hospital but it is appreciated that a number of patients may have nebulisers supplied by their GP. It was not possible to access these patients as we Number of consultations (median (IQR)) GP 6 (4-12) Hospital doctor 3 (1-5) only had the contact details for patients who have either been supplied their nebuliser from the hospital or who have had their nebuliser serviced there. A decision was also made to limit the potential contacts to patients who had had contact with the respiratory unit in the last year to avoid potential distress to relatives of deceased patients in the event that the respiratory unit had not been informed of this event.
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The results of this questionnaire survey indicate that there may be some problems with the use and servicing of home nebuliser systems. While the patients indicate that they have been informed of how to use and look after their nebuliser, the answers to the questions on the servicing and replacement of disposables indicate that these replacements may not be undertaken as suggested or recommended. Particular concern is raised by the infrequent changes of the tubing and the chambers and the frequency of cleaning of the chamber. Patients are supplied with replacement chambers and tubing when the nebuliser is serviced annually, and instructed that the chambers should be washed with warm soapy water, rinsed and left to dry after each use as recommended in the current BTS guideline on nebuliser use. 1 This evidence of reported infrequent cleaning is of concern as it has been reported that nebulisers that are less frequently cleaned may be a source of bacterial contamination. 7 Patient compliance also appears to be suboptimal. The majority of patient who are supplied with a nebuliser from the hospital are given a prescription indicating that the medicines should be used four times a day. The responses to this questionnaire suggest that most patients do not comply with this regimen. In the asthmatic population this may be due to patients not requiring therapy but they do not indicate a high as required usage. The reported compliance in patients with COPD of 42.5% lies within the compliance of 57% (+/À34.5%) reported by Corden et al. 6 Regarding the side effects experienced by the patients, almost half of the patients experienced tremor and 80/98 (81.6%) experienced dry mouth every day, but only 23/49 (46.9%) experienced dry eyes. This is not entirely unexpected as the majority of patients were maintained on both salbutamol and ipratropium solutions. There are some limitations in the interpretation of these data. These arise from the use of a postal questionnaire which was intended to be completed by the patient. It would have been preferable for respondents to have indicated who completed the survey. Due to the anonymity of the questionnaire it was impossible to verify if the patient or some other third party completed the questionnaire. Where it was not possible to send reminders to non-respondents, a reply rate of nearly 60% is a reasonable outcome for this study. The number of questionnaires posted was chosen to achieve at least 100 replies and this was exceeded.

Conclusion
The results of this study indicate poor compliance with servicing and maintenance of nebulisers. Better information provision may have a role in improving compliance. The information gained from this study on patient behaviour will be used to facilitate a new patient information leaflet. Following the launch of this leaflet, a further study to investigate changes in behaviour and compliance with therapy is proposed.
